China’s National Medical Products Administration (NMPA) has amended guidance on record filing requirements for low-risk Class I medical devices in order to reflect broader updates to medical device and in vitro diagnostic (IVD) regulations, and has also identified relevant standards for China’s Unique Device Identification (UDI) system…
